We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

8 hedge funds and large institutions have $789K invested in China Pharma Holdings in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 6 → 8 (+2)

0% less ownership

Funds ownership: 0.01% → 0% (-0%)

21% less capital invested

Capital invested by funds: $998K → $789K (-$209K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$20.9K
2
UBS Group
UBS Group
Switzerland
+$11.1K
3
VF
Virtu Financial
New York
+$10.1K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$63.6K
2
BCM
Bridgeway Capital Management
Texas
-$28.8K
3
Renaissance Technologies
Renaissance Technologies
New York
-$14.4K
4
HF
HRT Financial
New York
-$5.03K

CPHI Hedge Fund Activity: Q2 2021 in Review

8 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2021, worth a combined $789K — down 21% from $998K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CPHI positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $20.9K. The largest seller was Citadel Advisors, cutting an estimated $63.6K.

  • 8 institutional investors held China Pharma Holdings (CPHI) as of Q2 2021, up from 6 in Q1 2021.
  • Funds reported $789K of China Pharma Holdings stock for Q2 2021, down 21% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q2 2021 and 0 closed out, a net change of +2 holders.
  • The largest China Pharma Holdings buyer in Q2 2021 was Millennium Management, an estimated $20.9K added.
  • The largest China Pharma Holdings seller in Q2 2021 was Citadel Advisors, an estimated $63.6K sold.

Based on aggregated 13F filings for Q2 2021.